Pfizer (NYSE:PFE) Given New $24.00 Price Target at UBS Group
Pfizer (NYSE:PFE – Free Report) had its target price decreased by UBS Group from $28.00 to $24.00 in a research note issued to investors on Tuesday,Benzinga reports. UBS Group currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms have also recently weighed in on PFE. Citigroup reaffirmed a […]
Pfizer (NYSE:PFE – Free Report) had its target price decreased by UBS Group from $28.00 to $24.00 in a research note issued to investors on Tuesday,Benzinga reports. UBS Group currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms have also recently weighed in on PFE. Citigroup reaffirmed a […]
